-
Mashup Score: 0Manufacturer Payments to Cardiologists and Use of Devices - 9 day(s) ago
This study examines whether payments from a left ventricular assist device manufacturer to cardiologists performing percutaneous coronary intervention were associated with any use of the devices.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Manufacturer Payments to Cardiologists and Use of Devices - 9 day(s) ago
This study examines whether payments from a left ventricular assist device manufacturer to cardiologists performing percutaneous coronary intervention were associated with any use of the devices.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet-
Just published in JAMA: Intravascular microaxial LVAD manufacturer payments (often modest: median value, $164; IQR, $64-$451) to cardiologists were associated with increased use of LVADs by cardiologists who perform PCIs https://t.co/pZ16ZnqwUa #Impella @Abiomed @JAMA_current https://t.co/h3bQ4ruUMT
-
-
Mashup Score: 4FDA Issues Safety Alert for Impella Left-Sided Blood Pump - 16 day(s) ago
Read it now on PracticeUpdate.com
Source: www.practiceupdate.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 18Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock - 20 day(s) ago
Background In selected patients with an acute myocardial infarction (AMI) complicated by Cardiogenic shock (CS), mechanical circulatory support with Impella may be beneficial, although conclusive evidence is still lacking. Nevertheless, it has been suggested that Impella initiation prior to primary PCI might improve survival. Objective To investigate the effect pre-PCI versus immediate post-PCI Impella initiation on short term mortality. Methods A prospective, single center, observational study, was performed including all patients with STEMI complicated by CS, treated with primary PCI and Impella. Thirty day mortality was compared between patients with Impella initiation pre-PCI and immediately post-PCI. Results A total of 88 patients were included. In the pre-PCI group (n = 21), admission heart rate was lower (84 versus 94 bpm, p = 0.04) and no IABP was implanted before Impella initiation, versus 17.9% in post-PCI group (n = 67), p = 0.04. Total 30-day all-cause mortality was 58%, an
Source: journals.plos.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Impella vs IABP: Urgent Need for RCT - 20 day(s) ago
An RCT data void on Impella vs intra-aortic balloon pump led to two observational studies at AHA showing worse outcomes for Impella. John Mandrola asks the investigators from one study, ‘What now?’
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 14Heart Pump Is Linked to 49 Deaths, the F.D.A. Warns - 21 day(s) ago
The agency faulted the device maker for delayed notice of mounting complications, citing increasing reports of how use of the device perforated the walls of the heart.
Source: www.nytimes.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 0Salvaging a Disaster: “Threading the Wrong Needle” - 6 month(s) ago
Available online 5 August 2023, 101115 Author links open overlay panel Brian Cothern MD a, Michael Kourany MD a, Gregory Elsner MD a, Sina Moainie MD b, James Hermiller MD
Source: www.sciencedirect.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support: A Practical Approach - 7 month(s) ago
Percutaneous ventricular assist devices (pVADs) are increasingly being used because of improved experience and availability. The Impella (Abiomed), a …
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Abiomed Recalls All Impella Left Sided Blood Pumps for Risk of Motor Damage After Contact with Transcatheter Aortic Valve Replacement (TAVR) Stent - 9 month(s) ago
July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions for Use (IFU) do not adequately address precautions to take when treating patients who have undergone transcatheter aortic valve replacement (TAVR). The IFU lacks guidance to clinicians on how to manage use of Impella in patients with TAVR and fails to describe how the issue may present if an Impella interacts with TAVR. There is a potential risk that the Impella motor housing may come into contact with the distal stent of a transcatheter aortic valve replacement (TAVR). The contact may damage or destroy the motor’s impeller blades. The damaged Impella system may have reduced blood flow or pump stop, which may delay therapy or fail to provide enough support to the patient. This could be life threatening in people who require high levels of support. There is also a risk that pieces of the broken blades could enter the patient’s bloodstream. Please be aware, this recall
Source: www.dicardiology.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Wolters Kluwer Health - 10 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Cardiologists, Latest HeadlinesTweet
Just published in JAMA: Intravascular microaxial LVAD manufacturer payments (often modest: median value, $164; IQR, $64-$451) to cardiologists were associated with increased use of LVADs by cardiologists who perform PCIs https://t.co/pZ16ZnqwUa #Impella @Abiomed @JAMA_current https://t.co/h3bQ4ruUMT